Crescendo Bioscience Secures $31,000,000 Series C Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8332f09c-f928-48a1-a652-ca65e0da9b7c&Preview=1 -
Date
9/8/2011 -
Company Name
Crescendo Bioscience -
Mailing Address
341 Oyster Point Blvd South San Francisco, CA 94080 -
Company Description
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases. -
Website
http://www.crescendobio.com -
Transaction Type
Venture Equity -
Transaction Amount
$31,000,000 -
Transaction Round
Series C -
Proceeds Purposes
The company will use the funding to accelerate commercialization of its Vectra DA diagnostic test and expand its pipeline of molecular diagnostic products for rheumatoid arthritis and other inflammatory diseases. -
M&A Terms
-
Venture Investor
Aeris Capital AG -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
Mohr Davidow Ventures
